39. Hepatic Encephalopathy: Treatment

  1. John WD McDonald Professor of Medicine2,
  2. Andrew K Burroughs Professor of Hepatology Consultant Physician/Hepatologist3,
  3. Brian G Feagan Professor of Medicine2 and
  4. M Brian Fennerty Professor of Medicine4
  1. Peter Ferenci and
  2. Christian Müller

Published Online: 22 JUL 2010

DOI: 10.1002/9781444314403.ch39

Evidence-Based Gastroenterology and Hepatology, Third Edition

Evidence-Based Gastroenterology and Hepatology, Third Edition

How to Cite

Ferenci, P. and Müller, C. (2010) Hepatic Encephalopathy: Treatment, in Evidence-Based Gastroenterology and Hepatology, Third Edition (eds J. W. McDonald, A. K. Burroughs, B. G. Feagan and M. B. Fennerty), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444314403.ch39

Editor Information

  1. 2

    Robarts Clinical Trials, Robarts Research Unit, University of Western Ontario, London, Ontario, Canada

  2. 3

    The Royal Free Sheila Sherlock Liver Centre, Royal Free Hospital, and University College London, London, UK

  3. 4

    Oregon Health and Science University, Division of Gastroenterology and Hepatology, Portland, Oregon, USA

Author Information

  1. Division of Gastroenterology and Hepatology, Medical University Vienna, Vienna, Austria

Publication History

  1. Published Online: 22 JUL 2010
  2. Published Print: 10 SEP 2010

ISBN Information

Print ISBN: 9781405181938

Online ISBN: 9781444314403

SEARCH

Keywords:

  • Design of clinical trials in hepatic encephalopathy;
  • hepatic encephalopathy (HE);
  • Evidence-based medicine and hepatic encephalopathy;
  • Treatment of hepatic encephalopathy;
  • Molecular adsorbent recirculating system (MARS);
  • Summary of recommended treatment of hepatic encephalopathy in clinical practice;
  • Organisation Mondiale de Gastroentérologie (OMGE);
  • The PSE (portal-systemic encephalopathy) index;
  • number connection tests (NCT);
  • Psychometric Hepatic Encephalopathy Score (PHES)

Summary

This chapter contains sections titled:

  • Design of clinical trials in hepatic encephalopathy

  • Natural history of HE

  • Methods to quantify

  • Evidence-based medicine and hepatic encephalopathy

  • Treatment of hepatic encephalopathy

  • Pharmacotherapy

  • Molecular adsorbent recirculating system (MARS)

  • Persistent HE type C

  • Minimal HE

  • Summary of recommended treatment of hepatic encephalopathy in clinical practice

  • Chronic therapy

  • References